Europe Bioreactors Market
The Europe Bioreactors Market size was valued at US$ 919.86 Mn in 2022 and is projected to reach US$ 1,732.95 Mn by 2030, growing at a CAGR of 8.2% during 2022 - 2030.
Report Coverage
- Scale: Lab-Scale Production, Pilot-Scale Production, Full-Scale Production
- Application: Microbial Application, Cell Culture Application
- Technology: Fed-Batch Bioreactors, Perfusion Bioreactors
- End User: Biopharma Manufacturers, Research and Development Organizations, Contract Manufacturing Organization
US$ 919.86 Mn
Market size in 2022
US$ 1,732.95 Mn
Market Size by 2030
8.2%
CAGR, 2022 - 2030
2023-2030
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Bioreactors Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Bioreactors Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Bioreactors Market Regional Analysis
6.2 Europe Bioreactors Market Revenue 2020-2030 (US$ Million)
6.3 Europe Bioreactors Market Forecast Analysis
7. Europe Bioreactors Market Analysis – by Scale
7.1 Lab-Scale Production
- 7.1.1 Overview
- 7.1.2 Lab-Scale Production: Europe Bioreactors Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Pilot-Scale Production
- 7.2.1 Overview
- 7.2.2 Pilot-Scale Production: Europe Bioreactors Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Full-Scale Production
- 7.3.1 Overview
- 7.3.2 Full-Scale Production: Europe Bioreactors Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. Europe Bioreactors Market Analysis – by Application
8.1 Microbial Application
- 8.1.1 Overview
- 8.1.2 Microbial Application: Europe Bioreactors Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Cell Culture Application
- 8.2.1 Overview
- 8.2.2 Cell Culture Application: Europe Bioreactors Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. Europe Bioreactors Market Analysis – by Technology
9.1 Fed-Batch Bioreactors
- 9.1.1 Overview
- 9.1.2 Fed-Batch Bioreactors: Europe Bioreactors Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Perfusion Bioreactors
- 9.2.1 Overview
- 9.2.2 Perfusion Bioreactors: Europe Bioreactors Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. Europe Bioreactors Market Analysis – by End User
10.1 Biopharma Manufacturers
- 10.1.1 Overview
- 10.1.2 Biopharma Manufacturers: Europe Bioreactors Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.2 Research and Development Organizations
- 10.2.1 Overview
- 10.2.2 Research and Development Organizations: Europe Bioreactors Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.3 Contract Manufacturing Organization
- 10.3.1 Overview
- 10.3.2 Contract Manufacturing Organization : Europe Bioreactors Market – Revenue and Forecast, 2020-2030 (US$ Million)
11. Europe Bioreactors Market – Europe Analysis
11.1 Overview
11.2 Europe- 11.2.1 Europe Bioreactors Market Breakdown, by Key Country, 2023 and 2030 (%)
- 11.2.1.1 Europe Bioreactors Market – Revenue and Forecast Analysis – by Country
- 11.2.1.1 UK: Europe Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.1.1 UK: Europe Bioreactors Market Breakdown, by Scale
- 11.2.1.1.2 UK: Europe Bioreactors Market Breakdown, by Application
- 11.2.1.1.3 UK: Europe Bioreactors Market Breakdown, by Technology
- 11.2.1.1.4 UK: Europe Bioreactors Market Breakdown, by End User
- 11.2.1.2 Germany: Europe Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.2.1 Germany: Europe Bioreactors Market Breakdown, by Scale
- 11.2.1.2.2 Germany: Europe Bioreactors Market Breakdown, by Application
- 11.2.1.2.3 Germany: Europe Bioreactors Market Breakdown, by Technology
- 11.2.1.2.4 Germany: Europe Bioreactors Market Breakdown, by End User
- 11.2.1.3 France: Europe Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.3.1 France: Europe Bioreactors Market Breakdown, by Scale
- 11.2.1.3.2 France: Europe Bioreactors Market Breakdown, by Application
- 11.2.1.3.3 France: Europe Bioreactors Market Breakdown, by Technology
- 11.2.1.3.4 France: Europe Bioreactors Market Breakdown, by End User
- 11.2.1.4 Russia: Europe Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.4.1 Russia: Europe Bioreactors Market Breakdown, by Scale
- 11.2.1.4.2 Russia: Europe Bioreactors Market Breakdown, by Application
- 11.2.1.4.3 Russia: Europe Bioreactors Market Breakdown, by Technology
- 11.2.1.4.4 Russia: Europe Bioreactors Market Breakdown, by End User
- 11.2.1.5 Italy: Europe Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.5.1 Italy: Europe Bioreactors Market Breakdown, by Scale
- 11.2.1.5.2 Italy: Europe Bioreactors Market Breakdown, by Application
- 11.2.1.5.3 Italy: Europe Bioreactors Market Breakdown, by Technology
- 11.2.1.5.4 Italy: Europe Bioreactors Market Breakdown, by End User
- 11.2.1.6 Rest of Europe: Europe Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.6.1 Rest of Europe: Europe Bioreactors Market Breakdown, by Scale
- 11.2.1.6.2 Rest of Europe: Europe Bioreactors Market Breakdown, by Application
- 11.2.1.6.3 Rest of Europe: Europe Bioreactors Market Breakdown, by Technology
- 11.2.1.6.4 Rest of Europe: Europe Bioreactors Market Breakdown, by End User
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Applikon Biotechnology BV
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 bbi-biotech GmbH
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Cellexus International Ltd
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 General Electric Co
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Merck KGaA
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Pall Corp
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 PBS Biotech Inc
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Sartorius AG
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Solaris Biotechnology SRL
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Thermo Fisher Scientific Inc
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations
Access the Full E Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
